David Wyatt

CEO at Aston Particle Technologies


David is a pharmaceutical scientist (holding a PhD in Surface Chemistry and Colloid Science) with extensive medicine development experience.

During 32 years with GlaxoSmithKline, he held a range of senior scientific and management positions spanning the development of 5 major new chemical entities from molecule selection to be amongst the gold standard respiratory medicines in today's marketplace.

Immediately prior to joining APT, David was the Vice-President and Head of the Respiratory Centre of Excellence for New Product Introduction within GSK Manufacturing and has a broad appreciation of what it takes to champion a good idea to bring it to industrial reality.



  • CEO

    Current role

View in org chart

Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.